Crossmark

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer

Crossref DOI link: https://doi.org/10.1186/s12951-019-0541-8

Published Online: 2019-10-17

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yuan, Shen-Jun

Xu, Yong-Hong

Wang, Chao

An, Hui-Chao

Xu, Hua-Zhen

Li, Ke

Komatsu, Naoki

Zhao, Li

Chen, Xiao https://orcid.org/0000-0001-5474-0205
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81671818)

Hubei Province health and family planning scientific research project, China (WJ2019Z010)

Science and Technology Program of Wuhan, China (2017060201010148)

Medical Science Advancement Program (Basic Medical Science) of Wuhan University, China (TFJC20. 18003)
License Information

Text and Data Mining valid from 2019-10-17

Version of Record valid from 2019-10-17
More Information

Article History

Received: 22 August 2019

Accepted: 9 October 2019

First Online: 17 October 2019

Competing interests

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below